Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06501898 · ClinicalTrials.gov registry record · NA
Tributyrin: Time Course & Efficacy to Improve Health & Performance
A NA study, sponsored by Florida State University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT06501898: Clinical Trial NA study, sponsored by Florida State University.
NCT06501898 is a NA study that was terminated before completion, run by Florida State University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06501898, a NA study, was terminated before completion, sponsored by Florida State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if tributyrin supplementation improves metabolite concentrations, overall health biomarkers, and performance in sedentary men and women. The study would further understand the potential usage of tributyrin as a health and performance increasing supplement through improving gut and immune health, sleep, and performance as well as reduce inflammation. Participants will supplement for tributyrin for 4 weeks and complete fecal metabolite measures, cardiovascular evaluation, sleep assessment, and exercise testing as well as provide blood samples.
Primary Outcome
Fecal butyrate concentration
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT CoreBiome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2024-08-19 |
| Est. Completion | 2025-03-01 |
| Phase | NA |
Why NCT06501898 stopped before completion
NCT06501898 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06501898 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06501898 about?
NCT06501898 is a clinical study titled "Tributyrin: Time Course & Efficacy to Improve Health & Performance". The purpose of this study is to determine if tributyrin supplementation improves metabolite concentrations, overall health biomarkers, and performance in sedentary men and women. The study would further understand the potential usage of tributyrin as a health and performance increasing supplement th...
What is the current status of trial NCT06501898?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2024-08-19. Estimated completion is 2025-03-01.
What interventions are being tested in trial NCT06501898?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), CoreBiome (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06501898?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06501898's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI